Insilico Medicine Earns Milestone Payment from Servier – First Oncology Program Hits Early‑Stage Drug Discovery Mark on Pharma.AI Platform
Insilico Medicine (HKG: 3696), an AI‑powered drug discovery company, announced that it has achieved an early‑stage drug discovery milestone in its multi‑year, AI‑driven R&D collaboration with French pharmaceutical group Servier,…
Empowering Chinese Pharma’s Global Expansion
Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
